Efficacy evaluation of an herbal compound in COVID-19

Efficacy evaluation of an herbal compound “Fluherb” on clinical symptoms and paraclinical parameters in highly suspected COVID-19 patients: a controlled randomized clinical trial.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200323046841N1

Enrollment

Registered

2020-03-28

Start date

2020-03-28

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19

Interventions

Intervention 1: Intervention group: This group will receive routine treatments for COVID-19 disease and will receive a suspension of extract of five herbs. Patients will receive a combination consiste

Eligibility

Sex/Gender

All

Age

No minimum to 70 Years

Inclusion criteria

Inclusion criteria: Hospitalized patients with clinical and CT scan findings strongly suspected of COVID -19 Relative stability in cardiovascular status Moderate and severe cases No organ damage

Exclusion criteria

Exclusion criteria: Pregnant and lactating women End stage patients

Design outcomes

Primary

Measure	Time frame
Changing the patient's clinical status in the COVID-19 clinical classification table. Timepoint: Before and after intervention. Method of measurement: Clinical and Paraclinical Indicators in COVID-19 Classification Table.	—

Secondary

Measure	Time frame
Cell blood count. Timepoint: Before and after the intervention. Method of measurement: Cell conuter.;Liver enzymes. Timepoint: Before and after the intervention. Method of measurement: spectrometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Yousefi

Mashhad University of Medical Sciences

yousefim@mums.ac.ir0091 51 38848930

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026